This study focused on two primary areas: 1. To determine what can be learned from biotech and drug development companies that suffered from financial problems and ultimately failed at the beginning of the 21st century. 2. To determine how intellectual capital developed in accordance with such...

The turnover of the companies in North Savo in 2011 was nearly 10 billion euros, of which industry accounted for just under a third. The industrial structure of the region is not strong, but on the other hand it is not alarmingly thin either, because it does have certain successful niches. North...

Tässä tutkimuksessa simuloidaan lääkekehitykseen suuntautuneiden pienten ja keskisuurten biotekniikkayritysten tulevaisuutta, erityispainopisteenä kansantaloudelliset implikaatiot. Simulaatiossa huomioidaan vaihtoehtoisia kehityspolkuja, joiden avulla on arvioitu erilaisten...

New technological applications are usually expected to increase the health care costs. But they can also spawn cost savings in the long run, for example, when making time-consuming diagnostic methods more efficient and facilitating targeted therapy. This study analyses how the implementation of...

The paper reports an empirical study on the non-financial value-added provided by Venture Capital investors to their investee firms. This study will use a four-class grouping of the various non-financial value-adding capabilities provided by VC firms, namely, scouting, monitoring, signalling and...

This study focuses on the non-financial value-added of venture capital investors (VCs) as perceived by the CEOs of Finnish biotechnology companies. It pays attention to differences in the value-added between informal venture capitalists, private sector venture capitalists and public sector...

Production and employment have grown faster in the Helsinki Region and in the Province of Uusimaa compared to growth rates for Finland as a whole. At the same time, the extent of specialisation has diminished. The production structure of this region is now much more similar to that of the...

The paper reports an empirical study on the overall importance and non-financial value-added provided by Venture Capital (VC) investors to their investee firms in biotechnology. The study compares the characteristics of firms that have obtained VC funding with those of firms that have not....